Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.

Main|Search|PHGKB






Last Posted: Nov 09, 2018

---

• Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
  Segura-Villalobos Federico et al. Revista espanola de cardiologia (English ed.) 2017 Jul 70(7) 604-606
• Modeling Hypertrophic Cardiomyopathy in a Dish
  NIH Director's Blog, November 8, 2018
• The genetics of hypertrophic cardiomyopathy.
  Akhtar Mohammed et al. Global cardiology science & practice 2018 Aug 2018(3) 36
• A stroke gene panel for whole-exome sequencing.
  Ilinca Andreea et al. European journal of human genetics : EJHG 2018 Oct
• Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.
  Naik Rakhi P, et al. Annals of internal medicine 2018 11 0. (9) 619-627
• Genotype-Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy.
  Li Shijie et al. Journal of the American Heart Association 2018 Oct 7(20) e009910
• Systematic review study supports that sickle cell trait increases risk for some health conditions- More research needed to clarify all health outcomes associated with SCT
  J Mjoseth, NHGRI, October 30, 2018
• When to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy.
  Christian Susan et al. Circulation. Genomic and precision medicine 2018 Aug 11(8) e002300
• Clinical predictors of informative genetic testing in hypertrophic cardiomyopathy.
  Naraen Akriti et al. European journal of preventive cardiology 2018 Oct 2047487318808044
• Cardiac Toxicities in the Era of Precision Medicine: Underlying Risk Factors, Targeted Therapies, and Cardiac Biomarkers.
  Blaes Anne H et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 May (38) 764-774

more